Extremely preterm infants, those born before the 28th week of pregnancy, are surviving in greater numbers and escaping serious illness, according to a comprehensive review of births in a National Institutes of Health research network.
The study, published in the Journal of the American Medical Association, reviewed the birth records of more than 35,000 premature infants born from 1993 to 2012 in 26 U.S. centers participating in the Neonatal Research Network, a program funded by NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The lead author was Barbara J. Stoll, M.D., chair of pediatrics at Emory University School of Medicine.
Among the major findings:
- Infants born at 23 and 24 weeks survived in greater numbers over the 20-year period. Of those born at 24 weeks, for example, only 52 percent survived in 1993 while 65 percent survived in 2012.
- A higher number of premature infants survived without major illnesses. For infants born at 27 weeks, for example, survival without major illness increased from 29 percent in 1993 to 47 percent in 2012.
Among the survivors, the researchers saw an increase in the rate of bronchopulmonary dysplasia a complication often resulting from respiratory therapy. Improvements in respiratory care appear to have saved many infants who otherwise may have died. Nonetheless, the infants’ under-developed lungs often sustain damage.
“NICHD has funded newborn care research for many years,” said Rosemary Higgins, M.D., who oversees NICHD’s Neonatal Research Network. “We’re now seeing the results of that investment in improvements in survival and outcomes.”
More than 450,000 premature babies are born each year in the United States. Higgins attributed the boost in survival to advances in maternal and newborn care, such as the increased use of antenatal steroids - these drugs are given to women at risk for preterm birth to help stimulate lung development in the fetus. In 1993, physicians gave antenatal steroids to only 24 percent of women at risk for delivering too early, according to the study. A 1995 NIH consensus statement on antenatal steroids led to the widespread use of the treatment. By 2012, doctors were giving the steroids to nearly 87 percent of at-risk pregnant women.
The study authors noted that the increase in survival of extremely preterm infants parallels an increase in cesarean sections in this age group. It’s possible, Dr. Higgins explained, that “physicians are more likely to perform the surgery than they were in previous years.” The surgery may result in a less traumatic birth for the infant and therefore may contribute to survival.
The study authors also stressed the need for continued research on the care of extremely premature infants. Although survival has increased over the past two decades, including survival without major illnesses, preterm birth in the United States still poses a substantial burden to families and society at-large, they wrote.
NICHD recently launched the Human Placenta Project, an initiative aimed at understanding the function of this major organ in real time during pregnancy. Investigators hope that by tracking a healthy placenta, they can gain clues about abnormal development, which ultimately may help improve preterm birth outcomes, among other benefits.
Reference
“Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012,” by Stoll, J. Barbara, Journal of the American Medical Association. September 8, 2015.
###
About the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): The NICHD sponsors research on development, before and after birth; maternal, child, and family health; reproductive biology and population issues; and medical rehabilitation. For more information, visit the Institute’s website at http://www.nichd.nih.gov/.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.
BACK TO TOP